SCICLONE PHARMACEUTICALS INT LTD has a total of 14 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Russian Federation. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SHIRE VIROPHARMA INC, PVP LABS PTE LTD and IMMUNOFRONTIER INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Russian Federation | 2 | |
#4 | Taiwan | 2 | |
#5 | Australia | 1 | |
#6 | Hong Kong | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Tuthill Cynthia | 6 |
#2 | King Robert S | 5 |
#3 | Romani Luigina | 4 |
#4 | Garaci Enrico | 4 |
#5 | Blobel Friedhelm | 4 |
#6 | Guan Xiangdong | 3 |
#7 | Wu Jianfeng | 3 |
#8 | Tuthill Cynthia W | 2 |
#9 | Enrico Garaci | 1 |
#10 | Luigina Romani | 1 |
Publication | Filing date | Title |
---|---|---|
EP3256150A1 | Thymosin alpha 1 for use in treatment of cystic fibrosis |